BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 8524426)

  • 1. [Agranulocytosis caused by clozapine: the importance of leukocyte monitoring and efficacy of hematopoietic growth factors].
    van Melick EJ; Touw DJ; Haak HL
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2437-40. PubMed ID: 8524426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
    Gullion G; Yeh HS
    J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-CSF and the management of clozapine-induced agranulocytosis.
    Gerson SL
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW; Bogers JP; Giltay EJ
    Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF).
    Chengappa KN; Gopalani A; Haught MK; McChesney K; Baker RW; Schooler NR
    Psychopharmacol Bull; 1996; 32(1):111-21. PubMed ID: 8927660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
    Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
    J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V; Denton K; Borra D; Pulluri M; Sharma A
    Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
    Rajagopal G; Graham JG; Haut FF
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    Majczenko TG; Stewart JT
    South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF Dosing to Prevent Recurrent Clozapine-Induced Agranulocytosis.
    Freeman GM; Martin BA; Hu RJ
    Am J Psychiatry; 2016 Jun; 173(6):643. PubMed ID: 27245191
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
    Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW
    J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels.
    Pollmächer T; Fenzel T; Mullington J; Hinze-Selch D
    Pharmacopsychiatry; 1997 Jul; 30(4):118-21. PubMed ID: 9271776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of clozapine- and molindone-induced agranulocytosis with granulocyte colony-stimulating factor.
    Geibig CB; Marks LW
    Ann Pharmacother; 1993 Oct; 27(10):1190-4. PubMed ID: 7504534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G; Eskelinen S; Sailas E
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
    Schulte P
    Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
    Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
    Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
    Raveendranathan D; Sharma E; Venkatasubramanian G; Rao MG; Varambally S; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(5):574.e5-6. PubMed ID: 22902258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.